Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Opioids Market, by Application
1.4.2 North America Opioids Market, by Product Type
1.4.3 North America Opioids Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Opioids Market by Application
3.1 North America Pain Management Market by Country
3.2 North America Cough Treatment Market by Country
3.3 North America Diarrhea Treatment Market by Country
Chapter 4. North America Opioids Market by Product Type
4.1 North America Methadone Market by Country
4.2 North America Oxycodone Market by Country
4.3 North America Hydrocodone Market by Country
4.4 North America Fentanyl Market by Country
4.5 North America Codeine Market by Country
4.6 North America Morphine Market by Country
4.7 North America Other Product Type Market by Country
Chapter 5. North America Opioids Market by Country
5.1 US Opioids Market
5.1.1 US Opioids Market by Application
5.1.2 US Opioids Market by Product Type
5.2 Canada Opioids Market
5.2.1 Canada Opioids Market by Application
5.2.2 Canada Opioids Market by Product Type
5.3 Mexico Opioids Market
5.3.1 Mexico Opioids Market by Application
5.3.2 Mexico Opioids Market by Product Type
5.4 Rest of North America Opioids Market
5.4.1 Rest of North America Opioids Market by Application
5.4.2 Rest of North America Opioids Market by Product Type
Chapter 6. Company Profiles
6.1 Johnson and Johnson
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental &Regional Analysis
6.1.4 Research & Development Expenses
6.2 AstraZeneca PLC
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expenses
6.3 Boehringer Ingelheim International Gmbh
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Regional & Segmental Analysis
6.3.4 Research & Development Expenses
6.3.5 Recent strategies and developments:
6.3.5.1 Approvals and Trials:
6.4 Endo International PLC
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental Analysis
6.4.4 Research & Development Expenses
6.5 Mallinckrodt PLC
6.5.1 Company Overview
6.5.1 Financial Analysis
6.5.2 Segmental and Regional Analysis
6.5.3 Research & Development Expense
6.6 Sanofi S.A.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments:
6.6.5.1 Acquisition and Mergers:
6.7 Pfizer, Inc.
6.7.1 Company Overview
6.7.1 Financial Analysis
6.7.2 Regional Analysis
6.7.3 Research & Development Expense
6.7.4 Recent strategies and developments:
6.7.4.1 Approvals and Trials:
6.8 Teva Pharmaceutical Industries Ltd.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Regional Analysis
6.8.4 Research & Development Expenses
6.8.5 Recent strategies and developments:
6.8.5.1 Product Launches and Product Expansions:
6.8.5.2 Approvals and Trials:
6.9 Sun Pharmaceutical Industries Ltd.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.10. Purdue Pharma L.P.
6.10.1 Company Overview
Unique Offerings 
